UniSa - IRIS Institutional Research Information System

TRIGGIANI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.738
EU - Europa 1.518
AS - Asia 1.114
SA - Sud America 34
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
Totale 10.424
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.726
CN - Cina 516
UA - Ucraina 489
IT - Italia 427
VN - Vietnam 326
TR - Turchia 222
IE - Irlanda 209
DE - Germania 170
FI - Finlandia 81
SE - Svezia 74
AR - Argentina 30
GB - Regno Unito 27
IN - India 19
KR - Corea 8
NZ - Nuova Zelanda 8
CA - Canada 7
FR - Francia 7
RU - Federazione Russa 7
SG - Singapore 7
AU - Australia 6
HK - Hong Kong 6
BR - Brasile 4
CH - Svizzera 4
EU - Europa 4
CZ - Repubblica Ceca 3
ES - Italia 3
MK - Macedonia 3
PL - Polonia 3
BE - Belgio 2
BZ - Belize 2
CR - Costa Rica 2
JO - Giordania 2
JP - Giappone 2
NL - Olanda 2
PT - Portogallo 2
AT - Austria 1
BN - Brunei Darussalam 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MX - Messico 1
MY - Malesia 1
RO - Romania 1
SC - Seychelles 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 10.424
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.093
Woodbridge 1.132
Chandler 699
Jacksonville 661
Princeton 627
Houston 536
Wilmington 392
Dong Ket 326
Ashburn 262
Izmir 221
Dublin 206
Andover 147
Nanjing 133
Boardman 112
Pellezzano 103
Beijing 101
Washington 56
Salerno 54
Naples 51
Düsseldorf 50
Shenyang 49
Fairfield 45
Changsha 44
Hebei 42
Norwalk 39
Redwood City 37
Jiaxing 36
Nanchang 36
Buenos Aires 30
Dearborn 27
Tianjin 24
Mestre 18
Pune 15
Rome 15
Milan 14
Seattle 13
Cambridge 11
Latina 10
Falls Church 9
Jinan 8
Raleigh 8
San Diego 8
Chicago 7
Singapore 7
Hong Kong 6
Southampton 6
Lappeenranta 5
Auckland 4
London 4
Piacenza 4
San Jose 4
Columbus 3
Frechen 3
Giugliano in Campania 3
Gunzenhausen 3
Hefei 3
Indiana 3
Madrid 3
Orange 3
Romans D'isonzo 3
Saint Petersburg 3
Southend 3
Warsaw 3
Acerra 2
Albuquerque 2
Amman 2
Baltimore 2
Belize City 2
Bolano 2
Brussels 2
Böblingen 2
Castellammare Di Stabia 2
Catania 2
Changchun 2
Chennai 2
Desio 2
Espelkamp 2
Florence 2
Fuzhou 2
Genova 2
Guangzhou 2
Haikou 2
Hangzhou 2
Kunming 2
Lanzhou 2
Male Hostice 2
Melbourne 2
Munich 2
Napoli 2
Ningbo 2
Northridge 2
Otemae 2
Ottawa 2
Palermo 2
San Giorgio A Cremano 2
São Paulo 2
Tappahannock 2
Treviso 2
Vila Real 2
Villaricca 2
Totale 8.657
Salva come PNG Salva come JPEG
Nome #
A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema 129
La triptasi sierica nella diagnosi di mastocitosi sistemica in pazienti adulti senza lesioni cutanee 124
Antigen-induced generation of lyso-phospholipids in human airways. 122
Editorial overview: Immunomodulation: Modulation of the immune system: Per aspera ad astra 106
Biochemical functions of a pool of arachidonic acid associated with triglycerides in human inflammatory cells. 100
Allergia alimentare e probiotici: nuovi aspetti sulle interazioni tra il sistema immunitario ed i batteri commensali intestinali 100
Activation of human inflammatory cells by secreted phospholipases A2 100
L'acido ialuronico nella regolazione delle risposte infiammatorie ed immunologiche 98
Current concepts on diagnosis and treatment of mastocytosis. 98
Assay of antibody to group A streptococcal carbohydrate by enzyme-linked immunosorbent assay. 97
Activation of human basophils by staphylococcal protein A. I. The role of cyclic AMP, arachidonic acid metabolites, microtubules and microfilaments. 97
Antileucotrieni nell'asma bronchiale: bilancio e prospettive 95
Human Macrophages and Monocytes Express Functional Na+/Ca2+ Exchangers 1 and 3Sodium Calcium Exchange: A Growing Spectrum of Pathophysiological Implications 94
Fragments of truth: T-cell targets of polyclonal immunoglobulins in autoimmune diseases 94
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 92
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis 91
Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor 90
Arachidonic acid metabolism during antigen and ionophore activation of the mouse bone marrow derived mast cell. 89
Molecular diagnosis and the Italian Board for ISAC. 89
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group 89
Are mast cells MASTers in HIV-1 infection? 89
Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. 88
Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. 86
Anaphylaxis and cardiovascular diseases 85
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal 85
Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study 84
Sensitization to Common and Uncommon Pets or Other Furry Animals: Which May Be Common Mechanisms? 84
Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation. 83
Component resolved diagnosis (CRD): how much is it presently used by Italian allergists? 82
Research needs in allergy: an EAACI position paper, in collaboration with EFA 81
Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis 81
Triggers and prodromal symptoms of angioedema attacks in patients with hereditary angioedema 81
Expression and function of angiopoietins and their tie receptors in human basophils and mast cells 80
What we should learn from the London Olympics 79
Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell. 78
Control of arachidonate levels within inflammatory cells. 78
Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. 78
Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: The Italian experience 78
Oxidative stress markers are increased in patients with mastocytosis 77
Role of human mast cells and basophils in bronchial asthma. 77
Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. 77
Management of chronic spontaneous urticaria: practical parameters 77
Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema 77
Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils 77
Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. 76
Mastocytosis presenting as cardiac emergency 76
Molecular and cellular biology of mast cells and basophils. 75
Mutational Spectrum of the C1 Inhibitor Gene in a Cohort of Italian Patients with Hereditary Angioedema: Description of Nine Novel Mutations 75
Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases 75
Simplexide Induces CD1d-Dependent Cytokine and Chemokine Production from Human Monocytes 74
Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol. 74
Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18). 73
Metabolism of platelet-activating factor in the guinea-pig heart. 73
Advances in the classification and treatment of mastocytosis: Current status and outlook toward the future 73
Non lymphomatous clonal B-Cell populations in enlarged lymph nodes in acquired immunodeficiency syndrome. 73
Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor. 72
Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. 72
Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production. Influence of duration and dosage. 72
Metabolism of lipid mediators in human basophils and mast cells. 72
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives 72
360 degree perspective on allergic rhinitis management in Italy: A survey of GPs, pharmacists and patients 72
Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages. 71
Potential benefit of omalizumab in respiratory diseases 71
A unique case of angioedema with anti-C1 inhibitor antibodies and normal C1 inhibitor levels 71
Stress and Psychological Factors in the Variable Clinical Phenotype of Hereditary Angioedema in Children: A Pilot Study 71
Role of human FcεRI+ cells in HIV-1 infection 71
Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell. 70
Perioperative anaphylactic risk score for risk-oriented premedication. 70
Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. 69
Phenotypical and functional heterogeneity of human lung macrophages 69
Chemical mediators and the human heart. 68
Heterogeneity of human mast cells and basophils. Effects of a putative 5-lipoxygenase inhibitor. 67
Recent advances in our understanding of the biochemical interactions between platelet-activating factor and arachidonic acid. 67
Studi tossicologici sugli effetti dell'idrochinone e del benzochinone sui basofili umani 67
HIV-1 envelope gp41 peptides promote migration of human FcεRI+ cells and inhibit IL-13 synthesis through interaction with formyl peptide receptors 67
Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. 66
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 66
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 66
Biomarkers for evaluation of mast cell and basophil activation 66
Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage. 65
Mast cells, basophils and their mediators 65
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 65
Mast cells as effector cells of innate immunity and regulators of adaptive immunity 65
Human mast cells and basophils in HIV-1 infection 65
Basophil count in neonates is not suitable for atopy predictivity. 64
Immunopharmacological modulation of mast cells 64
Pharmacological modulation of human mast cells and basophils 64
Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study. 63
Metabolism of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. 63
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy 63
A review of hereditary angioedema and recombinant human C1-inhibitor treatment 63
Inhibition of secretory phospholipase A2-induced cytokine production in human lung macrophages by budesonide 63
Secretory phospholipase A2: a putative mediator of airway inflammation 62
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; The American Academy of Allergy, Asthma & Immunology; And the European Academy of Allergology and Clinical Immunology 62
Lung Involvement in Rheumatoid Arthritis 62
Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: An expert opinion 61
Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. 60
Arachidonic acid remodeling in human inflammatory cells migrating to the lung in vivo. 60
Effect of activation of the H1 receptor on coronary hemodynamics in man. 59
Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colony-stimulating factor-primed human eosinophils. 59
Totale 7.735
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.018
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019349 0 0 0 0 0 0 0 0 0 77 260 12
2019/20201.145 384 5 139 21 75 27 96 15 97 64 206 16
2020/20211.133 21 82 95 12 151 46 150 22 91 11 99 353
2021/20221.047 9 3 4 18 10 19 9 44 166 139 137 489
2022/20231.742 184 104 59 200 244 390 12 165 260 6 93 25
2023/2024746 82 111 125 50 100 178 23 44 14 19 0 0
Totale 10.716